Pharming Group N.V.PHARNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-10.9%
5Y CAGR-18.9%
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-10.9%/yr
vs -17.4%/yr prior
5Y CAGR
-18.9%/yr
Recent acceleration
Acceleration
+6.5pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
2 yr
Consecutive declineCompressed
PeriodValueYoY Change
20242.42-38.0%
20233.90-12.7%
20224.46+30.5%
20213.42-25.1%
20204.56-33.7%
20196.88+74.4%
20183.95-46.3%
20177.36-18.1%
20168.99-15.4%
201510.62-